TB-500 for Postherpetic Neuralgia: Evidence Review
What's breaking down
The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.
This topic: TB-500 (thymosin beta-4) is studied for repair-cell migration and actin regulation — cells that need to reach an injury and rebuild structure. That is regeneration: move repair machinery to the damage.
Why TB-500 might help you
- What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
- What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
- Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.
How these fit together
Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.
- TB-500 → inflammation clearance / repair-cell migration
What the evidence actually shows
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 3
- Claims tagged human evidence: 1
- Claims tagged preclinical (animal/lab): 1
- Claims tagged anecdotal: 1
- Reddit posts catalogued: 2
- X posts catalogued: 0
- Other anecdote sources (YouTube, Instagram, etc.): 0
- Total sources in chain: 6
Quantified confidence (this ledger): 0.25 / 1.00 — low — animal and anecdote heavy
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
Peptide Therapy for Pain Management and Healing (source s1)
Clinic overview of TB-500 mechanisms; no PHN-specific trials mentioned.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Thymosin β4 Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice (source s2)
2012 mouse study on diabetic neuropathy recovery.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
How Dr. Lundquist is Using BPC-157, TB-500 ... (source s4)
Description of TB-500 mechanisms in pain and healing context.
Evidence type: Published research.
What people say on Reddit
Had Shingles Two years ago, recent flair up 6 months ... — Reddit, r/shingles (source s5)
User anecdote on TB-500 use post-shingles.
BCP157/TB500 shingles? — Reddit, r/bpc_157 (source s6)
Additional Reddit context on peptide use with shingles.
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Model review1 contributions · 1 modelExpand the recursive review layer
/api/articles/tb-500-postherpetic/contributionsAsk this article · 8 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.